The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Sp1 and the ‘hallmarks of cancer’
Open accessAbstract
For many years, transcription factor Sp1 was viewed as a basal transcription factor and relegated to a role in the regulation of so‐called housekeeping genes. Identification of Sp1's role in recruiting the general transcription machinery in the absence of a TATA box increased its importance in gene regulation, particularly in light of recent estimates that the majority of mammalian genes lack a TATA box. In this review, we briefly consider the history of Sp1, the founding member of the Sp family of transcription factors. We review the evidence suggesting that Sp1 is highly regulated by post‐translational modifications that positively and negatively affect the activity of Sp1 on a wide array of genes. Sp1 is over‐expressed in many cancers and is associated with poor prognosis. Targeting Sp1 in cancer treatment has been suggested; however, our review of the literature on the role of Sp1 in the regulation of genes that contribute to the ‘hallmarks of cancer’ illustrates the extreme complexity of Sp1 functions. Sp1 both activates and suppresses the expression of a number of essential oncogenes and tumor suppressors, as well as genes involved in essential cellular functions, including proliferation, differentiation, the DNA damage response, apoptosis, senescence and angiogenesis. Sp1 is also implicated in inflammation and genomic instability, as well as epigenetic silencing. Given the apparently opposing effects of Sp1, a more complete understanding of the function of Sp1 in cancer is required to validate its potential as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–341 of 341
Spengler, M. L., & Brattain, M. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600035200 · Cited by 84
Werner, H., STANNARD, B. S., Bach, M. A., LeRoith, D., & Roberts, C. T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91996-6 · Cited by 84
Sp1 Phosphorylation Regulates Apoptosis via Extracellular FasL-Fas Engagement
Kavurma, M. M., Santiago, F. S., Bonfoco, E., & Khachigian, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009251200 · Cited by 84
Wang, Y.-T., Chuang, J., Shen, M., Yang, W., Chang, W., & Hung, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.043 · Cited by 83
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
D'Costa, Z. J., Jolly, C., Androphy, E. J., Mercer, A., Matthews, C. M., & Hibma, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048954 · Cited by 83
Wu, J., Ling, X., Pan, D., Apontes, P., Song, L., Liang, P., Altieri, D. C., Beerman, T. A., & Li, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409350200 · Cited by 83
p300 plays a role in p16INK4a expression and cell cycle arrest
Wang, X., Pan, L., Feng, Y., Wang, Y., Han, Q., Han, L., Han, S., Guo, J., Huang, B., & Lü, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210821 · Cited by 82
Tumor suppressor p53 represses transcription of RECQ4 helicase
Sengupta, S., Shimamoto, A., Koshiji, M., Pedeux, R., Rusin, M., Spillare, E. A., Shen, J., Huang, E. L., Lindor, N. M., Furuichi, Y., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208380 · Cited by 81
Koutsodontis, G., Moustakas, A., & Kardassis, D. (2002) · Biochemistry · doi:10.1021/bi026141q · Cited by 80
Lee, Y. I., Lee, S., Lee, Y. I., Bong, Y., Hyun, S. W., Yoo, Y. D., Kim, S., Kim, Y. W., & Poo, H. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201760 · Cited by 80
Kumar, P., Yadav, V. K., Baral, A., Kumar, P., Saha, D., & Chowdhury, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr536 · Cited by 79
Belaguli, N. S., Aftab, M., Rigi, M., Zhang, M., Albo, D., & Berger, D. H. (2010) · Neoplasia · doi:10.1593/neo.10224 · Cited by 78
Pietrzak, M., & Puzianowska‐Kuźnicka, M. (2008) · Biological Chemistry · doi:10.1515/bc.2008.039 · Cited by 78
NMR Structure of Transcription Factor Sp1 DNA Binding Domain,
Oka, S., Shiraishi, Y., Yoshida, T., Ohkubo, T., Sugiura, Y., & Kobayashi, Y. (2004) · Biochemistry · doi:10.1021/bi048438p · Cited by 77
Todd, A. K., & Neidle, S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn078 · Cited by 76
Gilmour, J., Assi, S. A., Jägle, U., Kulu, D., van de Werken, H. J. G., Clarke, D., Westhead, D. R., Philipsen, S., & Bonifer, C. (2014) · Development · doi:10.1242/dev.106054 · Cited by 75
Lee, J.-A., Suh, D., Kang, J.-E., Kim, M.-H., Park, H., Lee, M.-N., Kim, J., Jeon, B.-N., Roh, H.-E., Yu, M.-Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414134200 · Cited by 75
Sroka, I. C., Nagle, R. B., & Bowden, G. T. (2007) · Neoplasia · doi:10.1593/neo.07193 · Cited by 74
Jiang, Y., Wang, L., Gong, W., Wei, D., Le, X., Yao, J. C., Ajani, J. A., Abbruzzese, J. L., Huang, S., & Xie, K. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-1198-2 · Cited by 74
Lee, T.-J., Jung, E. M., Lee, J. T., Kim, S., Park, J. W., Choi, K. S., & Kwon, T. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0426 · Cited by 73
Independent Repression of a GC-rich Housekeeping Gene by Sp1 and MAZ Involves the Same cis-Elements
Song, J., Ugai, H., Kanazawa, I., Sun, K., & Yokoyama, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010658200 · Cited by 72
Downregulation of transcription factor, Sp1, during cellular senescence
Oh, J., Han, J.-A., & Hwang, E. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.118 · Cited by 72
Chen, Y., Wang, Y., & Chang, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700264200 · Cited by 72
Sp1 Facilitates DNA Double-Strand Break Repair through a Nontranscriptional Mechanism
Beishline, K., Kelly, C. M., Olofsson, B. A., Koduri, S., Emrich, J., Greenberg, R. A., & Azizkhan‐Clifford, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-12 · Cited by 70
Self-citationKoutsodontis, G., Vasilaki, E., Chou, W., Papakosta, P., & Kardassis, D. (2005) · Biochemical Journal · doi:10.1042/bj20041980 · Cited by 70
Molecular Basis of the Synergistic Antiangiogenic Activity of Bevacizumab and Mithramycin A
Jia, Z., Zhang, J., Wei, D., Wang, L., Yuan, P., Le, X., Li, Q., Yao, J. C., & Xie, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3494 · Cited by 70
Krüger, I., Vollmer, M., Simmons, D. G., Elsässer, H., Philipsen, S., & Suske, G. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21222 · Cited by 69
Asanuma, K., Tsuji, N., Endoh, T., Yagihashi, A., & Watanabe, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3922 · Cited by 68
Chang, H., Liu, L., & Hung, W. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.11.001 · Cited by 68
Zheng, X., Matsubara, S., Diao, C. T. M., Hollenberg, M. D., & Wong, N. C. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011031200 · Cited by 67
Groisman, I. J., Benlimame, N., Slagle, B. L., Perez, M. H., Alpert, L., Song, D. J., Fotouhi‐Ardakani, N., Galipeau, J., & Alaoui‐Jamali, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010852200 · Cited by 67
Kitadai, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Haruma, K., Kajiyama, G., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90221-6 · Cited by 66
MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity
Liu, L., Ishihara, K., Ichimura, T., Fujita, N., Hino, S., Tomita, S., Watanabe, S., Saitoh, N., Ito, T., & Nakao, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807098200 · Cited by 66
Marconett, C. N., Sundar, S. N., Tseng, M., Tin, A. S., Tran, K. Q., Mahuron, K. M., Bjeldanes, L. F., & Firestone, G. L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr116 · Cited by 66
Down-regulation of ATM Protein Sensitizes Human Prostate Cancer Cells to Radiation-induced Apoptosis
Truman, J., Gueven, N., Lavin, M. F., Leibel, S. A., Kolesnick, R., FUKS, Z. Y., & Haimovitz‐Friedman, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503701200 · Cited by 65
Survivin beyond physiology: Orchestration of multistep carcinogenesis and therapeutic potentials
Athanasoula, K. C., Gogas, H. J., Polonifi, K., Vaiopoulos, G., Polyzos, A., & Mantzourani, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.014 · Cited by 65
Iwahori, S., Yasui, Y., Kudoh, A., Sato, Y., Nakayama, S., Murata, T., Isomura, H., & Tsurumi, T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.007 · Cited by 65
Trisciuoglio, D., Iervolino, A., Candiloro, A., Fibbi, G., Fanciulli, M., Zangemeister‐Wittke, U., Zupi, G., & Bufalo, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308938200 · Cited by 65
Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma
Seznec, J., Silkenstedt, B., & Naumann, U. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0266-x · Cited by 64
Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1
Su, K., Yang, X., Roos, M. D., Paterson, A. J., & Kudlow, J. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480281 · Cited by 64
Cooperation of E2F-p130 and Sp1-pRb Complexes in Repression of the Chinese Hamster dhfr Gene
Chang, Y., Illenye, S., & Heintz, N. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1121-1131.2001 · Cited by 64
Kim, K., Barhoumi, R., Burghardt, R. C., & Safe, S. H. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0326 · Cited by 63
Khan, S., Barhoumi, R., Burghardt, R. C., Liu, S., Kim, K., & Safe, S. H. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0100 · Cited by 60
Che-1 Arrests Human Colon Carcinoma Cell Proliferation by Displacing HDAC1 from the p21 Promoter
Padova, M. D., Bruno, T., Nicola, F. D., Iezzi, S., D’Angelo, C., Gallo, R., Nicosia, D., Corbi, N., Biroccio, A., Floridi, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306694200 · Cited by 60
Basha, R. M., Ingersoll, S. B., Sankpal, U. T., Ahmad, S., Baker, C. H., Edwards, J. R., Holloway, R. W., Kaja, S., & Abdelrahim, M. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.03.014 · Cited by 58
An Important von Hippel-Lindau Tumor Suppressor Domain Mediates Sp1-Binding and Self-Association
Cohen, H. T., Zhou, M., Welsh, A. M., Zarghamee, S., Scholz, H., Mukhopadhyay, D., Kishida, T., Zbar, B., Knebelmann, B., & Sukhatme, V. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1767 · Cited by 57
Nichols, A. F., Itoh, T., Zolezzi, F., Hutsell, S., & Linn, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg152 · Cited by 57
pRB induces Sp1 activity by relieving inhibition mediated by MDM2
Johnson‐Pais, T. L., Degnin, C., & Thayer, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051415898 · Cited by 56
Rafty, L. A., Santiago, F. S., & Khachigian, L. M. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.334 · Cited by 55
[Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang, X., Wei-qiang, P., Yi, Z., Zhu, S.-L., & Gan, Q.-H. (2007) · PubMed · Cited by 55
Zhao, J., Glasspool, R. M., Hoare, S. F., Bilsland, A. E., Szatmári, I., & Keith, W. N. (2000) · Neoplasia · doi:10.1038/sj.neo.7900114 · Cited by 54
Zhang, Y., Liao, M., & Dufau, M. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01725-06 · Cited by 54
Shahrabani-Gargir, L., Pandita, T. K., & Werner, H. (2004) · Endocrinology · doi:10.1210/en.2004-0613 · Cited by 54
Zhang, Y., Liao, M., & Dufau, M. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00560-06 · Cited by 53
Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
Xu, X., Wang, L., Abrams, J., & Gan, W. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-17 · Cited by 52
Resistance to TRAIL and how to surmount it
Maksimović‐Ivanić, D., Stošić‐Grujičić, S., Nicoletti, F., & Mijatović, S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8284-8 · Cited by 51
High-Mobility Group A2 Protein Modulates hTERT Transcription To Promote Tumorigenesis
Li, A. Y. J., Lin, H. H., Kuo, C., Shih, H.-M., Wang, C. C. C., Yen, Y., & Ann, D. K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05447-11 · Cited by 51
Sp1 Is Essential for p16INK4a Expression in Human Diploid Fibroblasts during Senescence
Wu, J., Xue, L., Weng, M., Sun, Y., Zhang, Z., Wang, W., & Tong, T. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000164 · Cited by 50
Wei, S., Chuang, H.-C., Tsai, W.-C., Yang, M., Ho, S., Paterson, A. J., Kulp, S. K., & Chen, C. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055376 · Cited by 49
Santiago, F. S., & Khachigian, L. M. (2004) · Circulation Research · doi:10.1161/01.res.0000141135.36279.67 · Cited by 48
Hockings, J. K., Degner, S. C., Morgan, S. S., Kemp, M. Q., & Romagnolo, D. F. (2008) · Breast Cancer Research · doi:10.1186/bcr1987 · Cited by 48
Suzuki, T., Muto, S., Miyamoto, S., Aizawa, K., Horikoshi, M., & Nagai, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302228200 · Cited by 48
Zhang, X., & Liu, Y. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00426.2002 · Cited by 48
Yarden, R. I., Friedman, E., Metsuyanim, S., Olender, T., Ben‐Asher, E., & Papa, M. Z. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9797-z · Cited by 47
Santra, M., Santra, S., Zhang, J., & Chopp, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05134.x · Cited by 47
Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics
Oleaga, C., Welten, S. M. J., Belloc, A., Solé, A. S., Rodríguez, L., Mencia-Trinchant, N., Selga, E., Tapias, A., Noé, V., & Ciudad, C. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.014 · Cited by 46
Salvatori, L., Pallante, P., Ravenna, L., Chinzari, P., Frati, L., Russo, M. A., & Petrangeli, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206784 · Cited by 46
Pathi, S. S., Li, X., & Safe, S. H. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22010 · Cited by 46
Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors
Dalvai, M., Mondésert, O., Bourdon, J., Ducommun, B., & Dozier, C. (2011) · Oncogene · doi:10.1038/onc.2010.588 · Cited by 44
Koos, R. D., Kazi, A. A., Roberson, M. S., & Jones, J. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1282.037 · Cited by 44
Faraldo, M. M., Rodrigo, I., Behrens, J., Birchmeier, W., & Cano, A. (1997) · Molecular Carcinogenesis · Cited by 44
Wei, M., Liu, B., Gu, Q., Su, L., Yu, Y., & Zhu, Z. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0115-3 · Cited by 43
Salvatori, L., Ravenna, L., Felli, M. P., Cardillo, M. R., Russo, M. A., Frati, L., Gulino, A., & Petrangeli, E. (2000) · Endocrinology · doi:10.1210/endo.141.6.7521 · Cited by 43
Azahri, N. S. M., Bartolo, B. A. D., Khachigian, L. M., & Kavurma, M. M. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24135 · Cited by 43
Low pH enhances Sp1 DNA binding activity and interaction with TBP
Torigoe, T. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg487 · Cited by 43
Gizard, F., Robillard, R., Barbier, O., Quatannens, B., Faucompré, A., Révillion-Carette, F., Peyrat, J., Staels, B., & Hum, D. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4335-4348.2005 · Cited by 42
Brg-1 Is Required for Maximal Transcription of the Human Matrix Metalloproteinase-2 Gene
Ma, Z., Chang, M. J., Shah, R. C., Adamski, J., Zhao, X., & Benveniste, E. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405438200 · Cited by 41
Regulation of the Estrogen Receptor α Minimal Promoter by Sp1, USF-1 and ERα
deGraffenried, L. A., Hopp, T. A., Valente, A. J., Clark, R. A., & Fuqua, S. A. W. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000025398.93829.78 · Cited by 41
Effects of theMDM2promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk
Knappskog, S., & Lønning, P. E. (2011) · Transcription · doi:10.4161/trns.2.5.16813 · Cited by 40
Rojo-Niersbach, E., Furukawa, T., & Tanese, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33778 · Cited by 40
Tu, C., Velmurugan, B. K., Day, C. H., Kuo, W., Yeh, S., Chen, R., Liao, C.-R., Chen, H., Tsai, F., Wu, W.-J., et al. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0085 · Cited by 40
Trinh, B. Q., Barengo, N., & Naora, H. (2011) · Oncogene · doi:10.1038/onc.2011.4 · Cited by 39
O‐GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1
Lim, K., & Chang, H.-I. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.007 · Cited by 39
MDM2promoter SNP285 and SNP309; phylogeny and impact on cancer risk
Knappskog, S., & Lønning, P. E. (2011) · Oncotarget · doi:10.18632/oncotarget.243 · Cited by 39
Ganapathy, M., Ghosh, R., Jianping, X., Zhang, X., Bedolla, R. G., Schoolfield, J. D., Yeh, I., Troyer, D. A., Olumi, A. F., & Kumar, A. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1389 · Cited by 39
Selected base sequence outside the target binding site of zinc finger protein Sp1
Nagaoka, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.4920 · Cited by 38
HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene
Aiello, A., Pandini, G., Sarfstein, R., Werner, H., Manfioletti, G., Vigneri, R., & Belfiore, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.050 · Cited by 37
Zhao, J., Bilsland, A. E., Hoare, S. F., & Keith, W. N. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00038-3 · Cited by 36
Shim, J. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.978 · Cited by 36
Jiang, Y., Liu, S., Chen, X. '., Cao, Y., & Tao, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.003 · Cited by 36
Wang, C., Chang, H., & Hung, W. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20660 · Cited by 35
O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors
Lim, K., & Chang, H.-I. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.121 · Cited by 35
Increased Chromatin Association of Sp1 in Interphase Cells by PP2A-mediated Dephosphorylations
Vicart, A., Lefebvre, T., Imbert, J., Fernandez, A., & Kahn‐Perlès, B. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.036 · Cited by 35
Transcriptional control of human T‐BET expression: The role of Sp1
Yu, J., Wei, M., Boyd, Z. S., Lehmann, E. B., Trotta, R., Mao, H. C., Liu, S., Becknell, B., Jaung, M., Jarjoura, D. G., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737088 · Cited by 35
Role of zinc finger structure in nuclear localization of transcription factor Sp1
Ito, T., Azumano, M., Uwatoko, C., Itoh, K., & Kuwahara, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.165 · Cited by 35
A variant of the Cockayne syndrome B geneERCC6 confers risk of lung cancer
Lin, Z., Zhang, X., Tuo, J., Guo, Y., Green, B., Chan, C., Tan, W., Huang, Y., Ling, W., Kadlubar, F. F., et al. (2007) · Human Mutation · doi:10.1002/humu.20610 · Cited by 35
Iwahori, S., Shirata, N., Kawaguchi, Y., Weller, S. K., Sato, Y., Kudoh, A., Nakayama, S., Isomura, H., & Tsurumi, T. (2007) · Journal of Virology · doi:10.1128/jvi.00568-07 · Cited by 35
Chk2 down-regulation by promoter hypermethylation in human bulk gliomas
Wang, H., Wang, S., Shen, L., Chen, Y., Zhang, X., Zhou, J., Wang, Z., Hu, C., Wu, Y., & Wang, H. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.11.023 · Cited by 34
Wang, S., Wang, M., Yin, S., Fu, G., Li, C., Chen, R., Li, A., Zhou, J., Zhang, Z., & Liu, Q. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.08.011 · Cited by 34
Liu, M. Y., Eyries, M., Zhang, C., Santiago, F. S., & Khachigian, L. M. (2005) · Blood · doi:10.1182/blood-2005-06-2377 · Cited by 33
Chae, J., Cho, J. H., Lee, K., Choi, N., Seo, K.-S., Kim, S. B., Lee, S.-H., & Shim, J. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1075 · Cited by 33
Tan, N. Y., Midgley, V. C., Kavurma, M. M., Santiago, F. S., Luo, X., Peden, R., Fahmy, R. G., Berndt, M. C., Molloy, M. P., & Khachigian, L. M. (2008) · Circulation Research · doi:10.1161/circresaha.107.167395 · Cited by 33
Kim, H. S., & Lim, I. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808734200 · Cited by 32
Astrinidis, A., Kim, J., Kelly, C. M., Olofsson, B. A., Torabi, B., Sorokina, E. M., & Azizkhan‐Clifford, J. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20739 · Cited by 32
Self-citation達彦, 鈴., 和夫, 石., Zhao, X., Wu, W., Wang, H., Lu, J., Wu, Q., Chen, X., Fan, W., Chen, H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq089 · Cited by 31
Identification of a novel Sp1 splice variant as a strong transcriptional activator
Infantino, V., Convertini, P., Iacobazzi, F., Pisano, I., Scarcia, P., & Iacobazzi, V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.047 · Cited by 31
Gueven, N., Keating, K. N., Fukao, T., Loeffler, H., Kondo, N., Rodemann, H. P., & Lavin, M. F. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10261 · Cited by 31
Sisci, D., Middea, E., Morelli, C., Lanzino, M., Aquila, S., Rizza, P., Catalano, S., Casaburi, I., Maggiolini, M., & Andò, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0713-6 · Cited by 29
Involvement of Sp1 in the transcriptional regulation of the rat insulin-like growth factor-1 gene
Zhu, J.-L., Kaytor, E. N., Pao, C.-I., Meng, X. P., & Phillips, L. S. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00207-0 · Cited by 29
The proximal GC-rich region of p16INK4a gene promoter plays a role in its transcriptional regulation
Wang, X., Feng, Y., Pan, L., Wang, Y., Xu, X., Lü, J., & Huang, B. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9427-4 · Cited by 29
Ma, L., Weeda, G., Jochemsen, A. G., Bootsma, D., Hoeijmakers, J. H. J., & van der Eb, A. J. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.2.217 · Cited by 29
Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene
Sasahara, R. M., Takahashi, C., Sogayar, M. C., & Noda, M. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000700014 · Cited by 29
Ito, T., Kitamura, H., Uwatoko, C., Azumano, M., Itoh, K., & Kuwahara, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.036 · Cited by 28
O-GlcNAc inhibits interaction between Sp1 and sterol regulatory element binding protein 2
Lim, K., & Chang, H.-I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.128 · Cited by 27
MDM2SNP309 Does Not Associate with Elevated MDM2 Protein Expression or Breast Cancer Risk
Krekac, D., Hrazdilová, K., Knoflíčková, D., Hrstka, R., Müller, P., Nenutil, R., & Vojtěšek, B. (2008) · Oncology · doi:10.1159/000139135 · Cited by 27
Transglutaminase-dependent Modulation of Transcription Factor Sp1 Activity
Han, J. A., & Park, S. C. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0612-5 · Cited by 27
Panno, M., Mauro, L., Marsico, S., Bellizzi, D., Rizza, P., Morelli, C., Salerno, M., Giordano, F., & Andò, S. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01848 · Cited by 27
Keating, K. E., Gueven, N., Watters, D. J., Rodemann, H. P., & Lavin, M. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204527 · Cited by 26
Kaytor, E. N., Zhu, J. L., Pao, C., & Phillips, L. S. (2001) · Endocrinology · doi:10.1210/en.142.3.1041 · Cited by 25
Singh, A., Battu, A., Mohareer, K., Hasnain, S. E., & Ehtesham, N. Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009912 · Cited by 25
Regulation of the Atm promoter in vivo
Gueven, N., Fukao, T., Luff, J., Paterson, C. A., Kay, G. F., Kondo, N., & Lavin, M. F. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20267 · Cited by 24
Ma, W., Horvath, G. C., Kistler, M. K., & Kistler, W. S. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.067082 · Cited by 23
Gene Structure, cDNA Sequence, and Expression of Murine Bak, a Proapoptotic Bcl-2 Family Member
Ulrich, E., Kauffmann-Zeh, A., Hueber, A., Williamson, J. A., Chittenden, T., Ma, A. I., & Evan, G. I. (1997) · Genomics · doi:10.1006/geno.1997.4858 · Cited by 22
Salvatori, L., Ravenna, L., Caporuscio, F., Principessa, L., Coroniti, G., Frati, L., Russo, M. A., & Petrangeli, E. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.03.007 · Cited by 20
Kang, J.-E., Kim, M., Lee, J.-A., Park, H., Lee, M.-N., Auh, C.-K., & Hur, M. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000087728 · Cited by 19
Bu, Y., Suenaga, Y., Ono, S., Koda, T., Song, F., Nakagawara, A., & Ozaki, T. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01144.x · Cited by 18
Han, W. D., Si, Y. L., Zhao, Y. L., Li, Q., Wu, Z. Q., Hao, H., & Song, H. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.12.009 · Cited by 18
Cadoret, A., Baron-Delage, S., Bertrand, F., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202013 · Cited by 18
Modulation of the Expression of Bloom Helicase by Estrogenic Agents
Iso, T., Futami, K., Iwamoto, T., & Furuichi, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.266 · Cited by 16
Dalvai, M., Mondésert, O., Bugler, B., Manenti, S., Ducommun, B., & Dozier, C. (2012) · Oncogene · doi:10.1038/onc.2012.524 · Cited by 16
Kavurma, M. M., & Khachigian, L. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20238 · Cited by 16
SREBP inhibits VEGF expression in human smooth muscle cells
Motoyama, K., Fukumoto, S., Koyama, H., Emoto, M., Shimano, H., Maemura, K., & Nishizawà, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.139 · Cited by 14
Kang, J., Tsai‐Morris, C., & Dufau, M. L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05337-11 · Cited by 14
Transcriptional Activation of Mina by Sp1/3 Factors
Lian, S., Potula, H. H. S. K., Pillai, M. R., Stry, M. V., Koyanagi, M., Chung, L., Watanabe, M., & Bix, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080638 · Cited by 13
Zhou, Z.-Q., & Walter, C. A. (1998) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02677493 · Cited by 13
Laniel, M., Poirier, G. G., & Guérin, S. L. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.04.003 · Cited by 12
Thiesen, H., & Schroder, B. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81239-2 · Cited by 12
Savickienė, J., Treigytė, G., Magnusson, K., & Navakauskienė, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.002 · Cited by 12
A Novel Evolutionarily Conserved Element Is a General Transcriptional Repressor of p21WAF1/CIP1
Xu, W., Zhu, Q., Wu, Z., Guo, H., Feng-juan, W., Mashausi, D. S., Zheng, C., & Li, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1236 · Cited by 8
The D-domain of Sp3 modulates its protein levels and activation of the p21CIP1/WAF1 promoter
Hammill, D., Jain, N., Armstrong, S. A., & Mueller, C. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.084 · Cited by 5
(1999) · PubMed
Cited by
Akt in cancer: Mediator and more
Revathidevi, S., & Munirajan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.002 · Cited by 691
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Vizcaíno, C., Mansilla, S., & Portugal, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.008 · Cited by 377
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Anjali, G., Kaur, S., Lakra, R., Taneja, J., Kalsey, G. S., Nagendra, A., Shrivastav, T. G., Gouri Devi, M., Malhotra, N., Kriplani, A., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.011 · Cited by 42
Metadata
- Authors
- Beishline, K., & Azizkhan‐Clifford, J.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 282
- Issue
- 2
- Pages
- 224-258
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2019732936
- Cited by
- 524
- References
- 341
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.